The global antibody therapeutics market is experiencing a period of remarkable growth. This momentum can be attributed to several factors, like the increasing prevalence of chronic diseases, advancements in biotechnology, and growing utilization of biologics. The market is estimated to expand at a compounding annual growth rate of Z% during the for